Zinc is a negative regulator of hepatitis C virus RNA replication

Kazuhisa Yuasa, Atsushi Naganuma, Ken Sato, Masanori Ikeda, Nobuyuki Kato, Hitoshi Takagi, Masatomo Mori

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background/Aims: Hepatitis C virus (HCV) infection is a significant global public health problem. In clinical studies, zinc has been closely related to the pathogenesis of chronic hepatitis C. However, the role of zinc in both viral replication and the expression of viral proteins remains unclear. We aimed to clarify the effect of zinc on the replication of HCV in vitro. Methods: We incubated subgenomic HCV replicon cells (sO) and genome-length HCV RNA-replicating cells (O) treated with several chemicals including trace elements. Total RNAs were collected and subjected to real-time reverse-transcriptase polymerase chain reaction in order to examine the level of HCV RNA replication, and Western blotting was performed to confirm the expression of viral proteins. Results: Iron salts and interferon-α suppressed HCV RNA replication and protein expression in both sO and O cells. Zinc salts effectively reduced the viral replication in the genome-length HCV RNA replication system but not in the subgenomic HCV replicon system. Conclusions: We demonstrated that zinc may play an important role as a negative regulator of HCV replication in genome-length HCV RNA-replicating cells. Zinc supplementation thus appears to offer a novel approach to the development of future strategies for the treatment of intractable chronic hepatitis C.

Original languageEnglish
Pages (from-to)1111-1118
Number of pages8
JournalLiver International
Volume26
Issue number9
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Virus Replication
Hepacivirus
Zinc
RNA
Replicon
Viral Proteins
Genome
Chronic Hepatitis C
Salts
Trace Elements
Virus Diseases
Reverse Transcriptase Polymerase Chain Reaction
Interferons
Real-Time Polymerase Chain Reaction
Iron
Public Health
Western Blotting

Keywords

  • Genome-length HCV RNA
  • Hepatitis C virus
  • Replication
  • Subgenomic HCV replicon
  • Zinc

ASJC Scopus subject areas

  • Hepatology

Cite this

Yuasa, K., Naganuma, A., Sato, K., Ikeda, M., Kato, N., Takagi, H., & Mori, M. (2006). Zinc is a negative regulator of hepatitis C virus RNA replication. Liver International, 26(9), 1111-1118. https://doi.org/10.1111/j.1478-3231.2006.01352.x

Zinc is a negative regulator of hepatitis C virus RNA replication. / Yuasa, Kazuhisa; Naganuma, Atsushi; Sato, Ken; Ikeda, Masanori; Kato, Nobuyuki; Takagi, Hitoshi; Mori, Masatomo.

In: Liver International, Vol. 26, No. 9, 11.2006, p. 1111-1118.

Research output: Contribution to journalArticle

Yuasa, K, Naganuma, A, Sato, K, Ikeda, M, Kato, N, Takagi, H & Mori, M 2006, 'Zinc is a negative regulator of hepatitis C virus RNA replication', Liver International, vol. 26, no. 9, pp. 1111-1118. https://doi.org/10.1111/j.1478-3231.2006.01352.x
Yuasa, Kazuhisa ; Naganuma, Atsushi ; Sato, Ken ; Ikeda, Masanori ; Kato, Nobuyuki ; Takagi, Hitoshi ; Mori, Masatomo. / Zinc is a negative regulator of hepatitis C virus RNA replication. In: Liver International. 2006 ; Vol. 26, No. 9. pp. 1111-1118.
@article{6403c72739df407e936edf905b5a1f2d,
title = "Zinc is a negative regulator of hepatitis C virus RNA replication",
abstract = "Background/Aims: Hepatitis C virus (HCV) infection is a significant global public health problem. In clinical studies, zinc has been closely related to the pathogenesis of chronic hepatitis C. However, the role of zinc in both viral replication and the expression of viral proteins remains unclear. We aimed to clarify the effect of zinc on the replication of HCV in vitro. Methods: We incubated subgenomic HCV replicon cells (sO) and genome-length HCV RNA-replicating cells (O) treated with several chemicals including trace elements. Total RNAs were collected and subjected to real-time reverse-transcriptase polymerase chain reaction in order to examine the level of HCV RNA replication, and Western blotting was performed to confirm the expression of viral proteins. Results: Iron salts and interferon-α suppressed HCV RNA replication and protein expression in both sO and O cells. Zinc salts effectively reduced the viral replication in the genome-length HCV RNA replication system but not in the subgenomic HCV replicon system. Conclusions: We demonstrated that zinc may play an important role as a negative regulator of HCV replication in genome-length HCV RNA-replicating cells. Zinc supplementation thus appears to offer a novel approach to the development of future strategies for the treatment of intractable chronic hepatitis C.",
keywords = "Genome-length HCV RNA, Hepatitis C virus, Replication, Subgenomic HCV replicon, Zinc",
author = "Kazuhisa Yuasa and Atsushi Naganuma and Ken Sato and Masanori Ikeda and Nobuyuki Kato and Hitoshi Takagi and Masatomo Mori",
year = "2006",
month = "11",
doi = "10.1111/j.1478-3231.2006.01352.x",
language = "English",
volume = "26",
pages = "1111--1118",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Zinc is a negative regulator of hepatitis C virus RNA replication

AU - Yuasa, Kazuhisa

AU - Naganuma, Atsushi

AU - Sato, Ken

AU - Ikeda, Masanori

AU - Kato, Nobuyuki

AU - Takagi, Hitoshi

AU - Mori, Masatomo

PY - 2006/11

Y1 - 2006/11

N2 - Background/Aims: Hepatitis C virus (HCV) infection is a significant global public health problem. In clinical studies, zinc has been closely related to the pathogenesis of chronic hepatitis C. However, the role of zinc in both viral replication and the expression of viral proteins remains unclear. We aimed to clarify the effect of zinc on the replication of HCV in vitro. Methods: We incubated subgenomic HCV replicon cells (sO) and genome-length HCV RNA-replicating cells (O) treated with several chemicals including trace elements. Total RNAs were collected and subjected to real-time reverse-transcriptase polymerase chain reaction in order to examine the level of HCV RNA replication, and Western blotting was performed to confirm the expression of viral proteins. Results: Iron salts and interferon-α suppressed HCV RNA replication and protein expression in both sO and O cells. Zinc salts effectively reduced the viral replication in the genome-length HCV RNA replication system but not in the subgenomic HCV replicon system. Conclusions: We demonstrated that zinc may play an important role as a negative regulator of HCV replication in genome-length HCV RNA-replicating cells. Zinc supplementation thus appears to offer a novel approach to the development of future strategies for the treatment of intractable chronic hepatitis C.

AB - Background/Aims: Hepatitis C virus (HCV) infection is a significant global public health problem. In clinical studies, zinc has been closely related to the pathogenesis of chronic hepatitis C. However, the role of zinc in both viral replication and the expression of viral proteins remains unclear. We aimed to clarify the effect of zinc on the replication of HCV in vitro. Methods: We incubated subgenomic HCV replicon cells (sO) and genome-length HCV RNA-replicating cells (O) treated with several chemicals including trace elements. Total RNAs were collected and subjected to real-time reverse-transcriptase polymerase chain reaction in order to examine the level of HCV RNA replication, and Western blotting was performed to confirm the expression of viral proteins. Results: Iron salts and interferon-α suppressed HCV RNA replication and protein expression in both sO and O cells. Zinc salts effectively reduced the viral replication in the genome-length HCV RNA replication system but not in the subgenomic HCV replicon system. Conclusions: We demonstrated that zinc may play an important role as a negative regulator of HCV replication in genome-length HCV RNA-replicating cells. Zinc supplementation thus appears to offer a novel approach to the development of future strategies for the treatment of intractable chronic hepatitis C.

KW - Genome-length HCV RNA

KW - Hepatitis C virus

KW - Replication

KW - Subgenomic HCV replicon

KW - Zinc

UR - http://www.scopus.com/inward/record.url?scp=33749589705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749589705&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2006.01352.x

DO - 10.1111/j.1478-3231.2006.01352.x

M3 - Article

C2 - 17032412

AN - SCOPUS:33749589705

VL - 26

SP - 1111

EP - 1118

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 9

ER -